Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
April 7, 2025 - Teva and Samsung Bioepis announced the launch of Epysqli (eculizumab-aagh), biosimilar to AstraZeneca’s Soliris (eculizumab).
Download PDF
Return to publications
